-
761
Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest.
Published 2025-01-01“…Regardless of the malaria transmission period, the results demonstrated that one or multiple episodes of EBV-DNAemia did not influence the longevity of DBPII immune responses to both strain-specific (Sal-1) or strain-transcending (DEKnull-2) antibodies. Also, the average time in which DBPII-responders lost their antibodies was unrelated to the EBV serostatus. …”
Get full text
Article -
762
-
763
-
764
Assessment of Immunological, Skeletal, and Thyroid Function Abnormalities in Paediatric Morphoea
Published 2025-01-01Subjects: “…anti-nuclear antibody…”
Get full text
Article -
765
Epitope-imprinted biomaterials with tailor-made molecular targeting for biomedical applications
Published 2025-03-01Subjects: Get full text
Article -
766
Akabane virus isolated from biting midges and its infection in local domestic animal, Yunnan, China: a field and laboratory investigation
Published 2025-01-01Subjects: Get full text
Article -
767
Dietary Iodine Intake and Pattern of Thyroid Disorders among the Ethnic Population of Eastern Himalayan Ranges of India
Published 2024-01-01Subjects: “…anti-thyroid peroxidase antibody…”
Get full text
Article -
768
Enhancing Virus Filter Performance Through Pretreatment by Membrane Adsorbers
Published 2025-01-01Subjects: Get full text
Article -
769
Quantifying LAGA mutated mouse IgG2a monoclonal antibody with a rapid pepsin digestion enabled immunoaffinity LC/MS/MS assay
Published 2024-12-01Subjects: Get full text
Article -
770
The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells
Published 2025-12-01Subjects: Get full text
Article -
771
-
772
HUBUNGAN KOMORBIDITAS DAN PERILAKU TERHADAP TITER ANTIBODI DAN TERPAPAR COVID-19 PASCA VAKSIN ASTRAZENECA DOSIS LENGKAP DI UTA 45 JAKARTA
Published 2024-11-01Subjects: Get full text
Article -
773
-
774
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
Published 2024-12-01“…With more than 20 anti-PD-1/PD-L1 antibodies currently marketed, anti-PD-1 therapy has become a cornerstone of tumor immunotherapy. …”
Get full text
Article -
775
The Peptide Vaccine Combined with Prior Immunization of a Conventional Diphtheria-Tetanus Toxoid Vaccine Induced Amyloid β Binding Antibodies on Cynomolgus Monkeys and Guinea Pigs
Published 2015-01-01“…The reduction of brain amyloid beta (Aβ) peptides by anti-Aβ antibodies is one of the possible therapies for Alzheimer’s disease. …”
Get full text
Article -
776
The Possible Role of Transplacentally-Acquired Antibodies to Infectious Agents, With Molecular Mimicry to Nervous System Sialic Acid Epitopes, as Causes of Neuromental Disorders: Prevention and Vaccine Implications
Published 2006-01-01“…Lessons from four-decade investigations of the epidemiology, immunology, pathogenesis, prevention and therapy of perinatal infectious agents, which invade directly the nervous system, have led us to propose a new indirect effect hypothesis: maternal transplacentally-acquired antibodies, to agents with epitope molecular mimicry with the developing nervous system, can cross the fetus/infant's blood–nervous system barriers to cause NMD's, clinically manifest years later.…”
Get full text
Article -
777
Detection of antibodies against H5 subtype highly pathogenic avian influenza viruses in multiple raccoons in Tokachi District, Hokkaido, Japan, from 2022 to 2023
Published 2025-01-01“…The neuraminidase inhibition test revealed that all five sera contained anti-N1 subtype antibodies, and one also contained anti-N8 subtype antibodies. …”
Get full text
Article -
778
A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein
Published 2021-12-01“…Consequently, some moderate cross-interaction of the antibodies to HPV16 L1 with the antigens of HPV6 L1 may be expected.…”
Get full text
Article -
779
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Published 2025-01-01“…Background ATOR-1017 (evunzekibart) is a human agonistic immunoglobulin G4 antibody targeting the costimulatory receptor 4-1BB (CD137). …”
Get full text
Article -
780